Objective: The prevalence of hyperprolactinemia in non-functioning pituitary
macroadenomas (NFPMAs) is not well known, and hyperprolactinemia caused by a NFPMA …

Abstract Tjeerdsma G, Sluiter WJ, Hew JM, Molenaar WM, de Lange WE, Dullaart RPF.
Hyperprolactinaemia is associated with a higher prevalence of pituitary—adrenal …

Hyperprolactinemia is a prevalent endocrine disorder presented in patients with non-
functional pituitary adenomas (NFPAs). However, the mechanism involved in …

The objective of this study was to evaluate characteristics that discriminate prolactinoma
from non-functioning pituitary macroadenoma with hyperprolactinemia. We included 117 …

Objective: Serum PRL levels at presentation may be useful in distinguishing between
disconnection hyperprolactinemia in non-secretory pituitary adenomas and prolactinomas in …

Materials and methods Between 1974 and 2000, 107 patients suffering from NFPA were
operated on at the University Hospital of Dr. Shariati. We defined NFPAs as patients with …

Background The differentiation of a pituitary non‐functioning macroadenoma from a
macroprolactinoma is important for planning appropriate therapy. Serum PRL levels have …

Clinically nonfunctioning pituitary adenomas (NFPA) are the most common pituitary tumors
after prolactinomas. The absence of clinical symptoms of hormonal hypersecretion can …

Purpose Men with prolactin-secreting tumors usually harbor macroadenomas. The degree of
pituitary dysfunction may vary among different adenoma size subgroups, as is recovery after …

Purpose Pituitary tumours are slowly progressing tumours, mostly benign, with a reported
global prevalence of 16.7%(22.5% in radiologic studies and 14.4% in autopsy studies) …